Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -18,000 | 241,000 | 201,000 | 156,000 | 194,000 |
| Other Working Capital | 3,871,000 | -968,000 | 864,000 | -1,340,000 | 1,771,000 |
| Other Operating Activity | 2,000 | 1,588,000 | 1,695,000 | 2,149,000 | 1,488,000 |
| Operating Cash Flow | $3,855,000 | $861,000 | $2,760,000 | $965,000 | $3,453,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -481,000 | -269,000 | -217,000 | -191,000 | -471,000 |
| Net Acquisitions | 119,000 | 58,000 | 2,696,000 | 135,000 | 47,000 |
| Purchase Sale Intangibles | 287,000 | -355,000 | 344,000 | -34,000 | 31,000 |
| Other Investing Activity | 641,000 | 7,000 | 531,000 | 145,000 | 339,000 |
| Investing Cash Flow | $-52,000 | $-560,000 | $2,831,000 | $-58,000 | $-370,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,481,000 | -2,806,000 | -2,902,000 | -116,000 | -1,162,000 |
| Debt Issued | 965,000 | -21,000 | N/A | N/A | -28,000 |
| Common Stock Issued | 1,000 | 2,000 | 3,000 | 23,000 | 10,000 |
| Dividend Paid | -946,000 | -946,000 | -1,144,000 | -941,000 | -941,000 |
| Other Financing Activity | -714,000 | -505,000 | 1,414,000 | -18,000 | -638,000 |
| Financing Cash Flow | $-2,175,000 | $-4,276,000 | $-2,629,000 | $-1,052,000 | $-2,759,000 |
| Exchange Rate Effect | -22,000 | -45,000 | -14,000 | 42,000 | -102,000 |
| Beginning Cash Position | 3,656,000 | 7,676,000 | 4,728,000 | 4,831,000 | 4,609,000 |
| End Cash Position | 5,262,000 | 3,656,000 | 7,676,000 | 4,728,000 | 4,831,000 |
| Net Cash Flow | $1,628,000 | $-3,975,000 | $2,962,000 | $-145,000 | $324,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,855,000 | 861,000 | 2,760,000 | 965,000 | 3,453,000 |
| Capital Expenditure | -845,000 | -648,000 | -402,000 | -344,000 | -765,000 |
| Free Cash Flow | 3,010,000 | 213,000 | 2,358,000 | 621,000 | 2,688,000 |